Alcoholism and other socio-demographic risk factors for adverse tb-drug reactions and unsuccessful tuberculosis treatment - Data from ten years' observation at the regional centre of pulmonology, bydgoszcz, Poland

Medical Science Monitor

Volumn 20, Issue , 2014, Pages 444-453

  Przybylski, Grzegorz ^a   Dabrowska, Anita ^a   Trzcińska, Hanna ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Alcoholism; Drug related side effects and adverse reactions; Tuberculosis Drug therapy

Indexed keywords

ETHAMBUTOL PLUS ISONIAZID PLUS PYRAZINAMIDE PLUS RIFAMPICIN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL ABUSE; ALCOHOLISM; ARTHRALGIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIOPSY; DRUG INDUCED DISEASE; FEMALE; GASTROINTESTINAL SYMPTOM; HEALTH CARE ACCESS; HUMAN; HYPERURICEMIA; LIVER TOXICITY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MYCOBACTERIUM TUBERCULOSIS; NEUROLOGIC DISEASE; OTOTOXICITY; POLAND; SKIN DEFECT; SPUTUM ANALYSIS; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TUBERCULOSIS;

AGED; ALCOHOLISM; ANTITUBERCULAR AGENTS; DEMOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; POLAND; RISK FACTORS; TREATMENT FAILURE; TUBERCULOSIS;

EID: 84897826561     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.890012     Document Type: Article

References (43)

1. World Health Organization: Global Tuberculosis Control 2010: Epidemiology Strategy Financing. World Health Organization; 2010
2. European Respiratory Society: European Lung White Book. Gibson J, Loddenkemper R, Sibille Y, Lundbäck B (eds.), 2013
3. Tuberculosis and Diseases of Respiratory System in Poland. annual report 2001-2013. Korzeniewska-Koseła M (ed.) Warsaw: Institute of Tuberculosis and Lung Diseases; 2009-2012 [in Polish]
4. Ismail I, Bulgiba A: Determinants of unsuccessful tuberculosis treatment outcomes in Malaysian HIV-infected patients. Prev Med, 2013, 57(Suppl.): 27-30
5. The provincial program for preventing and solving alcohol-related problems in Kujawy-Pomorze province through the year 2015. Report. Toruń, 2012 [in Polish]
6. Sipak M, Rowińska-Zakrzewska E: [Analysis of tuberculosis mortality in the Toruń province in the years 1990-1993]. Pneumonol Alergol Pol, 1998, 66(7-8): 404-11 [in Polish]
7. World Health Organization, International Union Against Tuberculosis and Lung Disease, Royal Netherlands Tuberculosis Association: Revised international definitions in tuberculosis control. Int J Tuberc Lung Dis, 2001; 5(3): 213-15.
8. Veen J, Raviglione M, Rieder HL et al: Standardized tuberculosis treatment outcome monitoring in Europe. Recommendations of a Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting by cohort analysis of treatment outcome in tuberculosis patients. Eur Respir J, 1998, 12: 505-10
9. Edwards IR, Aronson JK: Adverse drug reactions: definitions, diagnosis, and management. Lancet, 2000, 356: 1255-59
10. The Uppsala Monitoring Centre: The use of the WHO-UMC system for standardized case causality assessment. http://who-umc.org/Graphics/24734. pdf
11. Leung CC, Daley CL, Rieder HL, Yew WW: Chapter 13. Management of adverse drug events in TB therapy. In: Tuberculosis. Lange C, Migliori GB (eds.), European Respiratory Society Monograph 2012; 58: 167-93
12. Centres for Disease Control and Prevention: Appendix SUR I RVCT Form Completion Instructions version 1.20. http://ftp.cdc.gov/pub/Software/TIMS/Documentation.Instructions.pdf
13. Pincock TA. Alcoholism in tuberculosis patients. Can Med Assoc J, 1964, 91: 851-54
14. Fleming MF, Krupitsky E, Tsoy M et al: Alcohol and drug use disorders, HIV status and drug resistance in a sample of Russian TB patients. Int J Tuberc Lung Dis, 2006, 10: 565-70
15. Siemion-Szcześniak I, Kuś J: Impact of social risk factors on treatment outcome in patients with culture positive pulmonary tuberculosis (CPPTB). Pneumonol Alergol Pol, 2012, 80(5): 412-21
16. Korzeniewska-Koseła M. Tuberculosis in Poland - factors of treatment success. Pneumonol Alergol Pol, 2007; 75(Suppl.2): 1-104 [in Polish]
17. Laurenti P, Federico B, Raponi M et al: Knowledge, experiences, and attitudes of medical students in Rome about tuberculosis. Med Sci Monit, 2013; 19: 865-74
18. Breen RA, Miller RF, Gorsuch T et al: Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infection. Thorax, 2006; 61(9): 791-94
19. Lv X, Tang S, Xia Y et al: Adverse reactions due to directly observed treatment strategy therapy in Chinese tuberculosis patients: a prospective study. PLoS One, 2013, 8(6): e65037
20. Huang YS, Chern HD, Su WJ et al: Polymorphism of the N-acetyltransferase-2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis. Hepatology, 2002; 35: 883-89
21. Singla R, Sharma SK, Mohan A et al: Evaluation of risk factors for antituberculosis treatment-induced hepatotoxicity. Indian J Med Res, 2010; 132: 81-86
22. Shin SS, Mathew TA, Yanova GV et al: Alcohol consumption among men and women with tuberculosis in Tomsk, Russia. Cent Eur J Public Health, 2010; 18: 132-38
23. Kolappan C, Gopi PG, Subramani R, Narayanan PR: Selected biological and behavioural risk factors associated with pulmonary tuberculosis. Int J Tuberc Lung Dis, 2007; 11: 999-1003
24. Suhadev M, Thomas BE, Raja Sakthivel M et al: Alcohol Use Disorders (AUD) among tuberculosis patients: A study from Chennai, South India. PLoS One, 2011 [unpaginated]
25. Burman WJ, Cohn DL, Rietmeijer CA et al: Noncompliance with directly observed therapy for tuberculosis. Epidemiology and effect on the outcome treatment. Chest, 1997; 111: 1168-73
26. Wobeser W, Yuan L, Naus M: Outcome of pulmonary tuberculosis treatment in the tertiary care setting- Toronto 1992/1993. Tuberculosis Treatment Completion Study Group. CMAJ, 1999; 160: 789-94
27. Ottmani SE, Zignol M, Bencheikh N et al: Results of cohort analysis by category of tuberculosis retreatment cases in Morocco from 1996 to 2003. Int J Tuberc Lung Dis, 2006; 10(12): 1367-72
28. Dooley KE, Lahlou O, Ghali I et al: Risk factors for tuberculosis treatment failure, default, or relapse and outcomes of retreatment in Morocco. BMC Public Health, 2011; 28(11): 140
29. Mak A, Thomas A, Del Granado M et al: Influence of multidrug resistance on tuberculosis treatment outcomes with standardized regimens. Am J Respir Crit Care Med, 2008; 178(3): 306-12
30. Lönnroth K, Williams BG, Stadlin S et al: Alcohol use as a risk factor for tuberculosis- a systematic review. BMC Public Health, 2008; 8: article 289
31. Mathew TA, Ovsyanikova TN, Shin SS et al: Causes of death during tuberculosis treatment in Tomsk Oblast, Russia. Int J Tuberc Lung Dis, 2006; 10: 857-63
32. Duarte EC, Bierrenbach AL, Barbosa da Silva J Jr et al: Factors associated with deaths among pulmonary tuberculosis patients: a case-control study with secondary data. J Epidemiol Community Health, 2009; 63: 233-38
33. Pelaquin MH, Souzae Silva R, Ribeiro SA: Factors associated with death by tuberculosis in the eastern part of Sao Paulo city, 2001. J Bras Pneumol, 2007; 33: 311-17
34. Walpola HC, Siskind V, Patel AM et al: Tuberculosis-related deaths in Queensland, Australia, 1989-1998: characteristics and risk factors. Int J Tuberc Lung Dis, 2003; 7: 742-50
35. Kolappan C, Subramani R, Kumaraswami V et al: Excess mortality and risk factors for mortality among a cohort of TB patients from rural South India. Int J Tuberc Lung Dis, 2008; 12: 81-86
36. The Act of 6 September 2001 on infectious diseases and infections. Journal of Laws, 2001; 126: item. 1384, 9857-68 [in Polish]
37. White MC, Portillo CJ: Tuberculosis mortality associated with AIDS and drug or alcohol abuse: analysis of multiple cause-of-death data. Public Health, 1996, 110: 185-89
38. Anibarro L, Lires JA, Iglesias F et al: Social risk factors for noncompliance with tuberculosis treatment in Pontevedra, Spain. Gac Sanit, 2004; 18: 38-44
39. Menezes AMB, da Costa JD, Gonçalves H et al: [Incidence and risk factors for tuberculosis in Pelotas, a city in the South of Brazil]. Rev Bras Epidemiol, 1998; 1: 50-60
40. Castell S, Diel R, Loddenkemper R et al: [Are alcohol and drug addiction risk factors for default from tuberculosis treatment? - preliminary work for a case-control study including tuberculosis patients from Berlin and Hamburg, 2001-2009]. Gesundheitswesen, 2011; 73(12): 909-11
41. Miller M, Masztalerz J: [Characterization of patients with treatment failure in the Central Tuberculosis Registry]. Pneumonol Alergol Pol, 1995; 63(1-2): 21-26
42. Fiske C, Hamilton C, Stout J: Alcohol use and clinical manifestations of tuberculosis. J Infect 2008; 57(5): 385-91
43. Fevre AM, Hane F, Ndiaye A et al: Effectiveness of a strategy to improve adherence to tuberculosis treatment in a resource-poor setting: a cluster randomized controlled trial. JAMA, 2007; 297(4): 380-86